
What This Longevity Investor Knows That You Don't | Karl Pfleger, Founder of AgingBiotech.info, Co-Hosted with Dr. Greg Bailey, Chairman of Juvenescence
Longevity for Investors with Dr. Greg Bailey and Jess Larsen
00:00
Why aging is malleable and worth investing in
Karl explains the geroscience hypothesis: aging is modifiable and targeting it could prevent major chronic diseases and be highly valuable.
Transcript
Play full episode